Work

Leveraging Stage-Specific Promoters to Enhance Immune Cell Engineering in iPSC-Derived Cells for Cancer Immunotherapy

Year: 2024
Type: conference-abstract
Source: Blood
Language: English
Open Access status: closed
OpenAlex ID: W4405039548
Cites:
Cited by: 1
Related to: 10